Trademark: 98268774
Word
XIPDEQLI
Status
Pending
Status Code
686
Status Date
Tuesday, July 30, 2024
Serial Number
98268774
Mark Type
4
Filing Date
Tuesday, November 14, 2023
Published for Opposition
Tuesday, July 30, 2024
Trademark Owner History
GlaxoSmithKline Biologicals SA - Owner At Publication
Classifications
5 Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Trademark Events
Nov 14, 2023
New Application Entered
Feb 1, 2024
New Application Office Supplied Data Entered
Jun 20, 2024
Assigned To Examiner
Jun 23, 2024
Approved For Pub - Principal Register
Jul 10, 2024
Notification Of Notice Of Publication E-Mailed
Jul 30, 2024
Published For Opposition
Jul 30, 2024
Official Gazette Publication Confirmation E-Mailed
AMPVYON
VYXIPDY
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - Twit Solutions PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov